HLT 404 · Unit 3 of 6
Intellectual Property and Portfolio Strategy
Pharmaceuticals, Biotechnology and Life Sciences
Start unit · 4 lessons →Learning objectives
After completing this unit, you will be able to:
- Produce portfolio-ready deliverables
- Apply the frameworks in "Intellectual Property and Portfolio Strategy" to a real management decision
- Make progress on your Executive brief applied project
Why this matters
Intellectual Property and Portfolio Strategy is essential to Pharmaceuticals, Biotechnology and Life Sciences. Lessons build fluency with anchor-company examples, worked problems, and assessments on the unit page.
Lesson
Unit overview
Complete all 4 lessons in order. Each lesson follows the program authoring standard: conceptual prose, worked examples, practice problems, and managerial judgment prompts. Finish unit exercises and the knowledge check before marking the unit complete.
Connection to applied work
This unit feeds directly into Executive brief. As you read, capture notes, examples, and data you can reuse in that deliverable. Strong students finish each unit with a draft section of their project, not just highlights.
Practice
- Write a one-page summary of this unit in your own words without looking at the lesson.
- Find a real company example (public filing, news article, or personal experience) that illustrates the main concept.
- Draft one paragraph recommending an action a manager should take based on this unit.
- Add at least three terms from this unit to your course glossary.
Knowledge check
Answer these without notes before marking the unit complete:
- What is the central idea of "Intellectual Property and Portfolio Strategy"?
- What mistake do beginners most often make when applying this material?
- How does this unit help you complete Executive brief?
- What is one decision you face this month where this unit applies?
Key takeaways
- Produce portfolio-ready deliverables
- Business concepts only matter when they change a decision.
- Your HLT 404 assessment (Pharmaceuticals, Biotechnology and Life Sciences. Six units covering applied topics in this concentration.) rewards applied understanding, not memorization.
Unit assessment
Complete each section below. Score 80%+ on the quiz to finish this unit's assessment.
Exercises
Apply what you learned in this unit with structured practice.
Deliverable
300–500 word analysis document saved to your portfolio under HLT 404.
Rubric
- • Framework applied correctly (not just named)
- • Specific evidence from a real example
- • Clear recommendation with tradeoffs acknowledged
- • Professional writing with source citation
Deliverable
Problem solutions + 150-word reflection in your HLT 404 workbook.
Rubric
- • Attempted all practice items before checking answers
- • Honest reflection on errors
- • Identifies a specific review action
Case analysis
Analyze a case using frameworks from this unit.
Deliverable
2-page case write-up in your portfolio.
Rubric
- • Case facts are accurate and sourced
- • Analysis uses unit frameworks explicitly
- • Recommendation is justified with tradeoffs
- • Risks are specific, not generic
Knowledge quiz
Check your understanding before marking the unit complete.
1. CareBridge is deciding whether to license versus acquire a dermatology biologic patent estate. Which metric is most decision-grade for tracking progress?
2. CareBridge reports $1.80B revenue and 3.2% operating margin. A 0.2 percentage point margin improvement is approximately:
3. Which statement best describes value-based care (VBC) at CareBridge?
4. Primary downside risk for Intellectual Property and Portfolio Strategy is:
5. CareBridge has 620,000 attributed lives and 2,200 licensed beds. Why does this distinction matter for IP strategy, portfolio prioritization, and deal economics?
6. Which evidence label is appropriate after a single-site pilot improves upfront cash and patent expiry?
7. David Park asks which lever best connects Intellectual Property and Portfolio Strategy to execution. The best answer is:
8. CareBridge operating days cash is 42. Why include liquidity in Intellectual Property and Portfolio Strategy decisions?